Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to ...

Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of ...

National Cancer Institute, Singapore (NCIS), the Yong Loo Lin School of Medicine, National University of Singapore, Duke-NUS Medical School and National Cancer Centre Singapore (NCCS) unveil findings ...

In tandem with this breakthrough, a clinical trial has demonstrated the potential of an innovative treatment strategy ...

The clinical trial and a new study mark a significant leap in the fight against gastric cancer with peritoneal spread. Read ...

Pamiparib is under clinical development by BeiGene and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II drugs for Peritoneal Cancer have a 37% phase transition success ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Metastatic Uveal Melanoma.

It was aimed to evaluate long non-coding RNAs (lncRNAs) in terms of diagnosis and prognosis in colorectal cancer (CRC) cases with peritoneal metastasis who underwent cytoreductive surgery and ...

A tissue section from a mouse model of lung metastasis showing cancer cells (green) that have attracted and activated fibroblasts (red) to support the growth of a metastatic tumor. Image: Massagué Lab ...

Metastatic stomach cancer is cancer that has spread beyond your stomach to distant tissues. Treatment generally focuses on extending your life and reducing symptoms. Metastatic stomach cancer is ...